Bio valiuta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 589,847 | 398,726 | 579,486 | 540,617 | 1,128,304 | 761,514 | 3,021,848 | 395,522 |
| Profit before tax | 64,145 | -40,064 | 24,992 | 24,871 | 232,855 | -53,718 | -38,953 | -38,571 |
| Net profit | 54,291 | -40,064 | 23,696 | 23,315 | 198,228 | -53,718 | -38,953 | -38,571 |
| Equity | 167,118 | 127,054 | 150,750 | 174,065 | 372,293 | 318,575 | 279,622 | 241,051 |
| Liabilities | 101,621 | 80,920 | 84,116 | 59,039 | 85,996 | 187,053 | 81,348 | 70,358 |
| Non-current assets | 18,218 | 18,829 | 21,154 | 28,020 | 43,662 | 34,566 | 25,796 | 23,522 |
| Current assets | 250,315 | 188,850 | 213,531 | 204,718 | 414,286 | 470,536 | 334,379 | 287,000 |
| Total assets | 268,533 | 207,679 | 234,685 | 232,738 | 457,948 | 505,102 | 360,175 | 310,522 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 7,870 | - |
| Social insurance contributions | - | - | - | - | - | 11,264 | 7,197 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -43.4% | -32.4% | +45.3% | -6.7% | +108.7% | -32.5% | +296.8% | -86.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 20.2% | -19.3% | 10.1% | 10.0% | 43.3% | -10.6% | -10.8% | -12.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 32.5% | -31.5% | 15.7% | 13.4% | 53.2% | -16.9% | -13.9% | -16.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 9.2% | -10.0% | 4.1% | 4.3% | 17.6% | -7.1% | -1.3% | -9.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 10.9% | -10.0% | 4.3% | 4.6% | 20.6% | -7.1% | -1.3% | -9.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 0.6 | 0.6 | 0.3 | 0.2 | 0.6 | 0.3 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 87,385 | 54,997 | 105,361 | 120,137 | 202,086 | 160,319 | 906,563 | 197,761 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bio valiuta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-01-02 | 2025-01-05 | 3.24 |
| 2024-12-22 | 2024-12-31 | 3.24 |
| 2024-12-17 | 2024-12-20 | 3.24 |
| 2024-11-19 | 2024-11-25 | 3.24 |
| 2024-11-18 | 2024-11-18 | 465.24 |
| 2024-10-24 | 2024-11-17 | 4.10 |
| 2024-08-19 | 2024-09-15 | 0.47 |
| 2024-07-16 | 2024-07-30 | 884.66 |
| 2024-04-23 | 2024-05-13 | 0.96 |
| 2024-01-16 | 2024-01-18 | 801.04 |
| 2023-03-16 | 2023-03-19 | 927.06 |
| 2023-01-24 | 2023-01-31 | 34.16 |
| 2023-01-23 | 2023-01-23 | 33.98 |
| 2023-01-20 | 2023-01-22 | 34.16 |
| 2023-01-17 | 2023-01-19 | 33.98 |
| 2022-12-16 | 2023-01-01 | 34.93 |
| 2022-10-28 | 2022-11-13 | 1.27 |
| 2022-09-19 | 2022-09-19 | 1.07 |
| 2022-09-16 | 2022-09-18 | 1060.73 |
| 2022-08-23 | 2022-09-15 | 1.07 |
| 2022-07-25 | 2022-08-15 | 1.07 |
Bio valiuta - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bio valiuta, UAB (code 302567066) is a Private Limited Liability Company engaged in the collection of non-hazardous waste. In 2025, the company generated revenue of EUR 395.5K and recorded a net loss of EUR 38.6K, corresponding to a profit margin of -9.8%. Revenue declined sharply by 86.9% year on year from EUR 3.02M in 2024, and the two-year comparison also shows a lower level than in 2023, when revenue was EUR 761.5K. Losses were present throughout the period, but the negative result narrowed from EUR 53.7K in 2023 to EUR 39.0K in 2024 before remaining at EUR 38.6K in 2025. At year-end 2025, total assets stood at EUR 310.5K, equity at EUR 241.1K and liabilities at EUR 70.4K. The equity ratio was 77.6% and debt-to-equity 0.29, indicating a relatively conservative balance sheet. Asset turnover was 1.27x, while revenue per employee reached EUR 197.8K.